SK288031B6 - Propellant-free liquid inhalation formulation - Google Patents

Propellant-free liquid inhalation formulation Download PDF

Info

Publication number
SK288031B6
SK288031B6 SK526-2003A SK5262003A SK288031B6 SK 288031 B6 SK288031 B6 SK 288031B6 SK 5262003 A SK5262003 A SK 5262003A SK 288031 B6 SK288031 B6 SK 288031B6
Authority
SK
Slovakia
Prior art keywords
liquid pharmaceutical
pharmaceutical composition
acid
tiotropium
composition according
Prior art date
Application number
SK526-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK5262003A3 (en
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK288031(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SK5262003A3 publication Critical patent/SK5262003A3/sk
Publication of SK288031B6 publication Critical patent/SK288031B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
SK526-2003A 2000-10-31 2001-10-24 Propellant-free liquid inhalation formulation SK288031B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31
PCT/EP2001/012296 WO2002036591A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (2)

Publication Number Publication Date
SK5262003A3 SK5262003A3 (en) 2003-10-07
SK288031B6 true SK288031B6 (sk) 2012-12-03

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
SK526-2003A SK288031B6 (sk) 2000-10-31 2001-10-24 Propellant-free liquid inhalation formulation

Country Status (33)

Country Link
EP (1) EP1335729A2 (pt)
JP (1) JP4559703B2 (pt)
KR (1) KR100983208B1 (pt)
CN (1) CN1237970C (pt)
AR (1) AR038765A1 (pt)
AU (2) AU2174102A (pt)
BG (1) BG66425B1 (pt)
BR (1) BR0115016A (pt)
CA (1) CA2427583C (pt)
CZ (1) CZ305033B6 (pt)
DE (1) DE10152369A1 (pt)
EA (1) EA009068B1 (pt)
EC (1) ECSP034570A (pt)
EE (1) EE05343B1 (pt)
HK (1) HK1060569A1 (pt)
HR (1) HRP20030337A2 (pt)
HU (1) HUP0301377A3 (pt)
IL (2) IL155676A0 (pt)
ME (1) ME00242B (pt)
MX (1) MXPA03003750A (pt)
MY (1) MY132777A (pt)
NO (1) NO332524B1 (pt)
NZ (1) NZ526024A (pt)
PE (1) PE20020518A1 (pt)
PL (1) PL361001A1 (pt)
SA (1) SA01220503B1 (pt)
SK (1) SK288031B6 (pt)
TW (1) TWI296934B (pt)
UA (1) UA76435C2 (pt)
UY (1) UY26991A1 (pt)
WO (1) WO2002036591A2 (pt)
YU (1) YU33103A (pt)
ZA (1) ZA200303045B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9519501A (en) 2000-04-28 2001-11-12 Kosan Biosciences Inc Production of polyketides
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005035731A2 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
CN101128196B (zh) * 2005-03-16 2013-01-02 Meda制药有限及两合公司 用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合
AU2007267523B2 (en) * 2006-05-26 2012-02-09 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
TR200907237A2 (tr) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropyum kuru toz kombinasyonu
CN111936124A (zh) * 2018-07-26 2020-11-13 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN116196298A (zh) * 2018-07-26 2023-06-02 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
EP0835098B1 (de) * 1995-06-27 2002-09-04 Boehringer Ingelheim Pharma KG Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
AU3153797A (en) * 1996-06-04 1998-01-05 Procter & Gamble Company, The A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
CN1473044A (zh) 2004-02-04
IL155676A0 (en) 2003-11-23
WO2002036591A3 (de) 2002-07-25
ECSP034570A (es) 2003-06-25
JP2004523482A (ja) 2004-08-05
SK5262003A3 (en) 2003-10-07
SA01220503B1 (ar) 2007-03-10
NZ526024A (en) 2005-10-28
CA2427583C (en) 2008-02-12
ME00242B (me) 2011-05-10
MEP40708A (en) 2011-02-10
HRP20030337A2 (en) 2005-04-30
AU2002221741B2 (en) 2007-04-05
BG66425B1 (bg) 2014-04-30
WO2002036591A2 (de) 2002-05-10
BR0115016A (pt) 2005-05-03
HUP0301377A2 (hu) 2003-10-28
KR100983208B1 (ko) 2010-09-20
EE05343B1 (et) 2010-10-15
CA2427583A1 (en) 2002-05-10
YU33103A (sh) 2006-05-25
CZ305033B6 (cs) 2015-04-08
AU2174102A (en) 2002-05-15
EE200300202A (et) 2003-10-15
NO332524B1 (no) 2012-10-08
MXPA03003750A (es) 2004-10-15
NO20031914L (no) 2003-06-23
EA009068B1 (ru) 2007-10-26
BG107726A (bg) 2004-11-30
NO20031914D0 (no) 2003-04-29
CN1237970C (zh) 2006-01-25
MY132777A (en) 2007-10-31
JP4559703B2 (ja) 2010-10-13
EA200300483A1 (ru) 2003-12-25
CZ20031487A3 (cs) 2003-09-17
PE20020518A1 (es) 2002-07-12
IL155676A (en) 2012-05-31
KR20040010552A (ko) 2004-01-31
AR038765A1 (es) 2005-01-26
TWI296934B (en) 2008-05-21
DE10152369A1 (de) 2002-05-08
HUP0301377A3 (en) 2005-12-28
UA76435C2 (en) 2006-08-15
UY26991A1 (es) 2002-06-20
ZA200303045B (en) 2004-04-22
HK1060569A1 (en) 2004-08-13
EP1335729A2 (de) 2003-08-20
PL361001A1 (en) 2004-09-20

Similar Documents

Publication Publication Date Title
US6890517B2 (en) Inhalable formulation of a solution containing a tiotropium salt
JP4659160B2 (ja) 噴射剤フリーエアゾール製造用新規水性医薬製剤
US20020111363A1 (en) Inhalable formulation of a solution containing a tiotropium salt
AU2004275490B2 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
SK286939B6 (sk) Inhalačný roztok bez hnacieho plynu, ktorý obsahuje jednu alebo viacero solí tiotrópia v kombinácii s jednou alebo viacerými soľami salmeterolu, a jeho použitie
US20040019073A1 (en) Aerosol formulation for inhalation containing a tiotropium salt
AU2003298473B9 (en) Aerosol formulation for inhalation containing an anticholinergic agent
CA2575385A1 (en) Aerosol formulation for inhalation, containing an anticholinergenic agent
US20110038806A1 (en) Medicaments for inhalation comprising an anticholinergic and a steroid
SK288031B6 (sk) Propellant-free liquid inhalation formulation
CA2426074C (en) Inhalable formulation of a solution containing a tiotropium salt
MXPA04009917A (es) Medicamento que contiene esteroides y un nuevo anticolinergico.
CA2593272A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20211024